InvivoChem Cat #:V0077CAS #:1092939-16-6 (sulfate)Purity >=98%Description: Ruxolitinib sulfate, the sulfate salt of ruxolitinib which is also known as Jakafi, Jakavi, INC-424, INCB-18424 or INCB-018424, is the first-in class, potent, selective, and orally bioavailable JAK1/2 (Janus-associated kinase) inhibitor with IC50 of 3.3 nM/2.8 nM in cell-free assays, it exhibits > 130-fold selectivity for JAK1/2 versus JAK3. Ruxolitinib has potential antineoplastic and immunomodulating activities. It was approved in 2011 by FDA for the treatment of intermediate or high-risk myelofibrosis.
Description:References: Blood. 2010 Apr 15; 115(15):3109-17; N Engl J Med. 2012 Mar 1; 366(9):799-807; N Engl J Med. 2012 Mar 1; 366(9):787-98.
References:Related CAS: 1092939-17-7 (phosphate); 941678-49-5 (free base); 941685-37-6 (S-enantiomer)